Development Level

Tdark 57 | 7,003
Tbio 6 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

Disease

osteosarcoma 15 | 7,933
interstitial cystitis 13 | 2,299
periodontitis 11 | 269
lung cancer 10 | 4,466
ulcerative colitis 10 | 2,087
Multiple myeloma 9 | 1,327
chronic lymphosyte leukemia 9 | 232
psoriasis 9 | 6,685
tuberculosis 9 | 1,557
lung adenocarcinoma 8 | 2,713
cutaneous lupus erythematosus 7 | 1,056
Amebiasis 6 | 22
non-small cell lung cancer 6 | 2,798
pancreatic cancer 6 | 2,300
Cancer 5 | 2,346
Leukemia 5 | 88
Lymphoma 5 | 56
cystic fibrosis and chronic rhinosinusitis 5 | 213
non-small cell lung carcinoma 5 | 413
primary Sjogren syndrome 5 | 789
ovarian cancer 4 | 8,484
Chronic obstructive pulmonary disease 3 | 146
chronic rhinosinusitis 3 | 512
colon cancer 3 | 1,475
diabetes mellitus 3 | 1,663
esophageal adenocarcinoma 3 | 737
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung carcinoma 3 | 2,844
nasopharyngeal carcinoma 3 | 1,056
primary pancreatic ductal adenocarcinoma 3 | 1,271
Agammaglobulinemia 2 | 24
Allergic hypersensitivity disease 2 | 123
Breast cancer 2 | 3,094
Diffuse large B-cell lymphoma 2 | 41
Dysgammaglobulinemia 2 | 9
Lupus erythematosus 2 | 80
Macroglobulinemia 2 | 17
Myositis 2 | 24
Pick disease 2 | 1,893
X-linked agammaglobulinemia 2 | 7
cystic fibrosis 2 | 1,665
gastric cancer 2 | 430
medulloblastoma, large-cell 2 | 6,234
mucosa-associated lymphoid tissue lymphoma 2 | 480
posterior fossa group A ependymoma 2 | 1,511
subependymal giant cell astrocytoma 2 | 2,287
Acute cystitis 1 | 37
Amyloidosis 1 | 68
Arthropathy 1 | 34
Autoimmune hepatitis 1 | 13
Autoimmune thyroiditis 1 | 24
Brucellosis 1 | 24
Calcinosis 1 | 62
Candidiasis 1 | 48
Celiac disease 1 | 112
Chickenpox 1 | 6
Chlamydia 1 | 18
Cholangitis 1 | 20
Cholera 1 | 33
Diarrhea 1 | 155
Diphtheria 1 | 23
Duodenal ulcer 1 | 20
Echinococcosis 1 | 28
Gastritis 1 | 44
Gastroenteritis 1 | 46
Giardiasis 1 | 10
Glomerulonephritis 1 | 36
Goodpasture syndrome 1 | 6
Heart valve disease 1 | 24
Henoch-Schoenlein purpura 1 | 13
Hepatitis A 1 | 10
Herpes simplex 1 | 19
Herpes zoster 1 | 7
Immunoglobulin alpha deficiency 1 | 10
Leprosy 1 | 77
Measles 1 | 20
Meningoencephalitis 1 | 13
Mumps 1 | 10
Newcastle disease 1 | 13
Otitis media 1 | 32
Parotitis 1 | 6
Pelvic inflammatory disease 1 | 21
Periodontal disease 1 | 37
Pertussis 1 | 17
Pneumocystosis 1 | 18
Polyneuropathy 1 | 30
Q fever 1 | 11
Reactive arthritis 1 | 7
Respiratory Hypersensitivity 1 | 18
Rubella 1 | 14
Schistosomiasis 1 | 38
Stomatitis 1 | 19
Strongyloidiasis 1 | 9
Syphilis 1 | 18
Tetanus 1 | 66
Tonsillitis 1 | 18
Toxoplasmosis 1 | 16
Typhoid fever 1 | 22
X-linked hyper IgM syndrome 1 | 5

Tissue

Blood and immune system 50 | 17,995
Digestive Tract 50 | 18,473
Female tissues 50 | 18,647
Respiratory system 50 | 17,484
Skin and soft tissues 50 | 18,115
Liver and Pancreas 49 | 18,136
Urinary Tract 49 | 18,444
Cardiovascular System 47 | 17,958
Endocrine System 46 | 18,512
Nervous System 46 | 18,561
Male tissues 44 | 17,969

Target Family

Non-IDG 64 | 11,971
Enzyme 1 | 4,146
Kinase 1 | 634

Reactome Pathway

CD22 mediated BCR regulation 66 | 66
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Immunoglobulin kappa variable 3-11 IGKV3-11 Tdark Non-IDG 0.00000 0
Ig lambda-7 chain C region IGLC7 Tdark Non-IDG 228.7 0
Immunoglobulin lambda variable 1-44 IGLV1-44 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 1-2 IGHV1-2 Tdark Non-IDG 0.00000 0
Immunoglobulin kappa variable 3-15 IGKV3-15 Tdark Non-IDG 0.00000 0
Immunoglobulin kappa variable 2-28 IGKV2-28 Tdark Non-IDG 0.00000 0
Immunoglobulin kappa variable 2D-30 IGKV2D-30 Tdark Non-IDG 0.00000 0
Ig mu chain C region IGHM Tbio Non-IDG 0.00000 0
Ig delta chain C region IGHD Tbio Non-IDG 0.00000 0
Immunoglobulin heavy variable 4-59 IGHV4-59 Tdark Non-IDG 0.00000 0